Skip to content

EFFects of Thrombophilia on the Outcomes of Assisted Reproduction Technologies

EFFects of Thrombophilia on the Outcomes of Assisted Reproduction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02407730
Enrollment
687
Registered
2015-04-03
Start date
2015-01-31
Completion date
2018-05-31
Last updated
2019-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Birth Rate, Embryo Implantation, Reproductive Techniques, Thrombophilia

Brief summary

Both hereditary and acquired thrombophilia have been associated with recurrent miscarriage and pregnancy complications. Thrombophilia could favor the development of thrombosis of the maternal vasculature and obstacle placentation. Some studies have suggested a role of thrombophilia in the failure of assisted reproductive techniques although this association has been recently questioned. The scope of this study is to evaluate the effect of thrombophilia on the implantation rate and live birth rate in women undergoing ART. Design: prospective, observational study Primary end-point: live birth rate. Secondary end-points: implantation rate, venous thromboembolic events during ART up to 6 weeks post-partum

Interventions

None listed

Sponsors

G. d'Annunzio University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* women undergoing ART * age 18 years or older

Exclusion criteria

* ongoing anticoagulant therapy * previous venous thromboembolism * no informed consent

Design outcomes

Primary

MeasureTime frame
Live birth rateParticipants will be followed for the duration of the pregnancy, an expected average of 9 months

Secondary

MeasureTime frame
implantation rateParticipants will be followed from the implantation to the ultrasonography to document the gestational sac, an expected average of 7 weeks

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026